GENF.L Stock: Genflow Biosciences plc Stock Price, Analysis & Insights
Get live GENF.L stock price $2.13, comprehensive Genflow Biosciences plc stock analysis, charts, news, and expert forecast. Real-time GENF.L stock data and investment insights.
Loading chart data...
Investment Score
A systematic tri-factor framework that integrates valuation, business quality, and market momentum into one investment signal. This helps investors triage opportunities faster, while surfacing risk regimes that may require tighter position sizing or deeper due diligence.
Score unavailable for this asset.
0-39
Defensive posture
40-54
Mixed / wait for confirmation
55-69
Constructive setup
70-100
Attractive zone
Total Score
Value
Cheapness vs fundamentals and cash generation
Quality
Durability of profitability and balance sheet
Momentum
Price trend strength and persistence
Company Overview
Genflow Biosciences plc is a biotechnology firm dedicated to devising biological treatments aimed at confronting the impacts of aging. Their goal is to slow down or completely stop the aging process and reduce the frequency of age-related illnesses, ...
Company Information
- CEO
- Eric Jean Leire
- Sector
- Healthcare
- Industry
- Biotechnology
- Employees
- 5
Contact Information
- Website
- https://genflowbio.com
- Address
- 15 Ingestre Place
- Country
- GB
Investment Analysis & Business Insights
Investment Highlights
✓ Strong presence in the Healthcare sector with established market position
✓ Higher growth potential with elevated volatility (Beta: 2.31)
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for Genflow Biosciences plc shareholders
- ⚠Market volatility can significantly impact stock price, especially for smaller companies
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for Genflow Biosciences plc
- ⚠Investors should consider how Genflow Biosciences plc fits within their overall portfolio allocation
- ⚠Valuation metrics suggest potential, but require fundamental analysis
Market Cap
12.04M
P/E Ratio (TTM)
-2.12
Beta
2.31
Data Sources & Methodology
Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.
Related Stocks
Compare GENF.L with peer companies:
- Price
- $2.95+7.27% (1D)
- Market cap
- 1.25B
- Price
- $10.50+0.00% (1D)
- Market cap
- 407.17M
- Price
- $0.58+6.23% (1D)
- Market cap
- 196.81M
- Price
- $0.95+0.00% (1D)
- Market cap
- 265.65M
- Price
- $8.65+0.00% (1D)
- Market cap
- 804.93M
- Price
- $0.20+0.00% (1D)
- Market cap
- 426.17M
- Price
- $0.18+0.28% (1D)
- Market cap
- 384.56M
- Price
- $6.20-0.80% (1D)
- Market cap
- 640.46M
- Price
- $7.25+0.00% (1D)
- Market cap
- 516.45M
- Price
- $0.38+0.00% (1D)
- Market cap
- 567.52M
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.
Healthcare (1D)
48/100 ⭐⭐⭐
- Overall
- -0.9%
- NYSE
- -1.3%
- NASDAQ
- -0.5%
| Sector | 1D | 1W | 1M | P/E | Score |
|---|---|---|---|---|---|
| Technology | +0.8% | +1.1% | +3.0% | 52.1 | 77/100⭐⭐⭐⭐⭐ |
| Basic Materials | +0.9% | +0.3% | +2.0% | 28.0 | 76/100⭐⭐⭐⭐⭐ |
| Financial Services | -0.0% | +0.9% | +1.5% | 19.8 | 71/100⭐⭐⭐⭐⭐ |
| Industrials | -0.1% | -0.8% | +2.9% | 43.0 | 64/100⭐⭐⭐⭐ |
| Communication Services | -0.5% | -1.0% | +0.7% | 22.0 | 53/100⭐⭐⭐ |
| Healthcare | -0.9% | -1.9% | +1.6% | 30.5 | 48/100⭐⭐⭐ |
| Consumer Defensive | +0.4% | +1.3% | -2.8% | 31.1 | 44/100⭐⭐⭐ |
| Energy | +0.9% | -3.2% | +0.3% | 36.1 | 34/100⭐⭐ |
| Real Estate | +0.1% | -1.5% | -0.5% | 50.0 | 30/100⭐⭐ |
| Utilities | +1.5% | -1.7% | -5.5% | 26.1 | 29/100⭐⭐ |
| Consumer Cyclical | -0.8% | -0.1% | -0.6% | 55.3 | 25/100⭐⭐ |
Sector returns combine NYSE and NASDAQ averages. P/E is the latest blended sector multiple. Sector score ranks each sector vs peers using percentile ranks (not fixed thresholds): 48% 1M + 24% 1W + 8% 1D + 20% P/E (lower P/E ranks higher). Data as of 2026-06-12.